Morphine Sulfate NDC 67877-671

NDC codes

FDA NDC Directory

Product NDC (as listed)67877-671Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67877-0671Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67877-671-01	67877067101	100 TABLET in 1 BOTTLE (67877-671-01)Marketed from Feb 11, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Morphine Sulfate
Generic name (nonproprietary): morphine sulfate
Active ingredients: Morphine sulfate — 30 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ascend Laboratories, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212451
Marketing start: Feb 11, 2021
Listing expires: Dec 31, 2026
DEA schedule: CII
Other FDA classes: Full Opioid Agonists (Mechanism)
Identifiers: Product ID 67877-671_2d263950-4148-405d-b582-13857ac88044SPL ID 2d263950-4148-405d-b582-13857ac88044SPL set ID 07593aa4-f2c4-4d6e-b186-ab2a4ecaa38aRxCUI 892582, 892672UNII X3P646A2J0UPC 0367877671017
Pharmacologic class: Opioid Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N467877067101 followed by a unit qualifier and the quantity

Package 67877-0671-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 10, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Morphine sulfate tablets are indicated for the management of: adult and pediatric patients weighing at least 50 kg and above with acute pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. adults with chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use: Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration, [see Warnings and Precautions ( 5.1 )], reserve morphine sulfate tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): Have not been …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212451

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212451
Product	Strength	Form · route	Labeler	Product NDC
Morphine Sulfate	Morphine sulfate 15 mg/1	TabletOral	Bryant Ranch Prepack	63629-8459
Morphine Sulfate	Morphine sulfate 15 mg/1	TabletOral	American Health Packaging	60687-617
Morphine Sulfate	Morphine sulfate 30 mg/1	TabletOral	Bryant Ranch Prepack	71335-9662
Morphine Sulfate	Morphine sulfate 15 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-893
Morphine Sulfate	Morphine sulfate 15 mg/1	TabletOral	Ascend Laboratories, LLC	67877-670